Key result
Highly sensitive troponin assays enable accurate measurement at and below the 99th percentile, improving the diagnosis of acute myocardial infarction and risk prediction in coronary disease.
This review highlights the potential of highly sensitive troponin assays to improve the diagnosis of acute myocardial infarction and long-term risk assessment in coronary disease.
Answers are grounded in this paper and cite their sources.
May improve AMI diagnosis and risk stratification; leaves open assay standardization and prospective outcome trials.
Cardiac troponin is the biomarker of choice for the diagnosis of acute myocardial infarction. Recent consensus recommendations have adopted a concentration of troponin above the 99th percentile of a healthy population to diagnose myocardial infarction. Until recently, there was no assay capable of achieving recommended precision; however, with the development of "highly sensitive" troponin assays, it is now possible to accurately measure troponin concentrations at and below the current 99th percentile of a healthy population. These assays have enormous potential in not only identifying more patients with acute myocardial infarction, and providing superior risk prediction in those so afflicted, in addition highly sensitive troponins assays may be useful for long-term risk assessment of the patient with coronary disease. In this article, we will review the clinical applications, novel concepts, challenges, and limitations of using highly sensitive troponins assays.
No takes yet. Share an insight, caveat, or question.
Mohammed et al. (2009) conducted a review in Acute myocardial infarction and coronary disease. Highly sensitive troponin assays was evaluated. Highly sensitive troponin assays enable accurate measurement at and below the 99th percentile, improving the diagnosis of acute myocardial infarction and risk prediction in coronary disease.
Synapse has enriched 10 related papers. Consider them for comparative context: